Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cerulean appoints Susan L Kelley to board

This article was originally published in Scrip

Executive Summary

Cambridge, Massachusetts-based Cerulean Pharma has named Dr Susan L Kelley to the company's board of directors. From 2008 to 2011, Dr Kelley was chief medical officer of the Multiple Myeloma Research Consortium and its sister organization, the Multiple Myeloma Research Foundation. She also currently serves as a member of the board of directors of ArQule and Alchemia, oncology-focused biotechnology companies.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts